Epoetin beta: Difference between revisions
m (Bot: Automated text replacement (-{{SIB}} + & -{{EJ}} + & -{{EH}} + & -{{Editor Join}} + & -{{Editor Help}} +)) |
m (Robot: Automated text replacement (-{{WikiDoc Cardiology Network Infobox}} +, -<references /> +{{reflist|2}}, -{{reflist}} +{{reflist|2}})) |
||
Line 30: | Line 30: | ||
==References== | ==References== | ||
{{reflist}} | {{reflist|2}} | ||
==External links== | ==External links== |
Latest revision as of 17:10, 4 September 2012
Identifiers | |
---|---|
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
WikiDoc Resources for Epoetin beta |
Articles |
---|
Most recent articles on Epoetin beta Most cited articles on Epoetin beta |
Media |
Powerpoint slides on Epoetin beta |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Epoetin beta at Clinical Trials.gov Clinical Trials on Epoetin beta at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Epoetin beta
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Epoetin beta Discussion groups on Epoetin beta Patient Handouts on Epoetin beta Directions to Hospitals Treating Epoetin beta Risk calculators and risk factors for Epoetin beta
|
Healthcare Provider Resources |
Causes & Risk Factors for Epoetin beta |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Epoetin beta (rINN) (Template:PronEng) is a synthetic, recombinant[1] form of erythropoietin. It stimulates erythropoiesis (increases red blood cell levels) and is used to treat anemia, commonly associated with chronic renal failure and cancer chemotherapy.
Epoetin is marketed under the trade names NeoRecormon.[2] It is only sold in Europe.
References
- ↑ Dunn CJ, Markham A (1996). "Epoetin beta. A review of its pharmacological properties and clinical use in the management of anaemia associated with chronic renal failure". Drugs. 51 (2): 299–318. PMID 8808169.
- ↑ Amgen - Products. URL: http://www.amgen.com/patients/prca.html. Accessed on: October 21, 2007.
External links
- Pages with script errors
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Infobox drug articles without a structure image
- Chemical articles without CAS registry number
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs missing an ATC code
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Drugs
- Growth factors
- Erythropoiesis-stimulating agents